EUVIMEDEUVIMED entdecken
Open Access

RDW Predicts Fibrosis in Patients with Chronic Hepatitis B Having Persistently Normal ALT Levels

Basak Yilmaz Guller, Erdinc Gulumsek, Hilmi Erdem Sumbul, Begum Seyda Avci, Adnan Tas

Ethiopian Journal of Health Sciences · 2023

DOI: 10.4314/ejhs.v33i4.5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ethiopian Journal of Health Sciences, 2023. Verfasst von Basak Yilmaz Guller und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Health Sciences - Adana City Research and Training Hospital, Adana, Turkey. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Alanine Transaminase, Liver Cirrhosis, Erythrocyte Indices. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: There are studies on the determination of hepatic fibrosis with noninvasive markers but data about liver biopsy results and noninvasive markers in patients with chronic hepatitis B (CHB) are limited. The aim of this study is to determine the relationship between pathological findings and noninvasive markers, and to determine the marker that predicts fibrosis in patients with consistently normal serum alanine aminotransferase (ALT) levels, diagnosed with CHB and undergoing liver biopsy. METHODS: A total of 122 patients with CHB, 29 of them with HbeAg (+), aged 30 years and older, HBV DNA > 2000 IU / ml, and serum ALT levels measured four times in the last year, were consistently normal, and 93 of them with HbeAg (-) were included in the study. Demographic characteristics of patients, laboratory parameters, histological activity index (HAI) and fibrosis values ​​obtained in liver biopsy, and noninvasive markers (AP (age-platelet) index, APRI (AST/Platelet ratio) and FIB-4 score, neutrophil/lymphocyte ratio, mean platelet volume (MPV) and erythrocyte distribution width (RDW) were recorded. RESULTS: The relationship between RDW value and fibrosis was statistically significant in the HbeAg (+) group (p0.05 for each). CONCLUSION: It has been shown that the RDW value can be used to predict fibrosis in CHB patients with normal ALT and HbeAg (+), and the cut-off value for RDW is 12.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicAlanine TransaminaseLiver CirrhosisErythrocyte IndicesBiomarkersHepatitis B e AntigensHumansMaleFemaleAdultMiddle AgedLiverBiopsyYoung Adult

Stichwörter der Autor:innen

APRIChronic Hepatitis BFIB-4Liver fibrosisMPVRDW

Substanzen

Alanine TransaminaseBiomarkersHepatitis B e Antigens

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Health Sciences - Adana City Research and Training Hospital, Adana, Turkey.
  • Department of Gastroenterology, University of Health Sciences - Adana City Research and Training Hospital, Adana, Turkey.

Zitieren

APA

Guller, B. Y., Gulumsek, E., Sumbul, H. E., Avci, B. S., & Tas, A. (2023). RDW Predicts Fibrosis in Patients with Chronic Hepatitis B Having Persistently Normal ALT Levels. Ethiopian Journal of Health Sciences. https://doi.org/10.4314/ejhs.v33i4.5

Vancouver

Guller BY, Gulumsek E, Sumbul HE, Avci BS, Tas A. RDW Predicts Fibrosis in Patients with Chronic Hepatitis B Having Persistently Normal ALT Levels. Ethiopian Journal of Health Sciences. 2023. doi:10.4314/ejhs.v33i4.5

BibTeX
@article{Guller2023,
  author = {Guller, Basak Yilmaz and Gulumsek, Erdinc and Sumbul, Hilmi Erdem and Avci, Begum Seyda and Tas, Adnan},
  title = {RDW Predicts Fibrosis in Patients with Chronic Hepatitis B Having Persistently Normal ALT Levels},
  journal = {Ethiopian Journal of Health Sciences},
  year = {2023},
  doi = {10.4314/ejhs.v33i4.5}
}
Kostenlos starten →